利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

215 条记录 (耗时 0.039 秒)

    Organic Thin-Film Solar Cell Using Fullerene Derivative for Electron Acceptor and Method of Manufacturing the Same
    1.
    发明申请
    Organic Thin-Film Solar Cell Using Fullerene Derivative for Electron Acceptor and Method of Manufacturing the Same 审中-公开
    有机薄膜太阳能电池使用富勒烯衍生物用于电子受体及其制造方法

    公开(公告)号：US20100163103A1

    公开(公告)日：2010-07-01

    申请号：US12509582

    申请日：2009-07-27

    申请人： Lee-Yih Wang ,  Chin-Wei Liang ,  Jui-Chi Lin ,  Wen-Hsien Ho

    发明人： Lee-Yih Wang ,  Chin-Wei Liang ,  Jui-Chi Lin ,  Wen-Hsien Ho

    IPC分类号： H01L31/042 ,  H01L51/48 ,  C07C69/616

    CPC分类号： C07C69/00 ,  B82Y10/00 ,  C07C67/08 ,  C07C67/347 ,  C07C69/753 ,  C07C2604/00 ,  H01L51/0036 ,  H01L51/0047 ,  H01L51/4253 ,  Y02E10/549 ,  Y02P70/521 ,  C07C69/38

    摘要： A fullerene derivative for electron acceptor is disclosed. Introducing a benzylalkyl group into the fullerene derivative can increase the affinity of the fullerene derivative with electron donors, and introducing an alkyl group into the fullerene derivative can increase the solubility of the fullerene derivative with an organic solvent. In addition, an organic thin-film solar cell and a method of manufacturing the same are further disclosed. An annealing process can be employed to improve the crystallization and to reduce the phase separation state of a photoactive layer that is formed by the fullerene derivative and the electron acceptor. Thereby, the fullerene derivative is facilitated to enhance the solar energy to electricity conversion efficiency of the resultant organic thin-film solar cell.

    摘要翻译： 公开了一种用于电子受体的富勒烯衍生物。 在富勒烯衍生物中引入苄基烷基可以增加富勒烯衍生物与电子给体的亲和性，并且将引入烷基的富勒烯衍生物可以增加富勒烯衍生物与有机溶剂的溶解度。 此外，还公开了有机薄膜太阳能电池及其制造方法。 可以采用退火工艺来改善结晶并降低由富勒烯衍生物和电子受体形成的光活性层的相分离状态。 由此，富勒烯衍生物有助于提高所得有机薄膜太阳能电池的太阳能与电力转换效率。

    Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents
    4.
    发明申请
    Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents 失效
    至少20个碳原子的单不饱和脂肪酸和全氢环戊烷菲核组合分子及其作为减肥剂的用途

    公开(公告)号：US20030114431A1

    公开(公告)日：2003-06-19

    申请号：US10227983

    申请日：2002-08-26

    发明人： Michael P. Girouard

    IPC分类号： A61K031/56 ,  A61K009/127 ,  C07J001/00

    CPC分类号： C07J1/00 ,  A61K31/215 ,  A61K31/56 ,  A61K31/567 ,  C07C69/00

    摘要： The pharmaceutical and/or cosmetic compositions for treatment of obesity and/or overweight contain an effective amount of a fatty-acid monoester of an estrogen and a fatty acid wherein the estrogen is preferably estrone, diethylstilbestrol, estriol, estradiol or ethinyl estradiol and the fatty acid is eicosenoic acid, especially cis 11 eicosenoic, although cis 5, cis 8, and cis 13 eicosenoic acid are also effective. The C-22 fatty acid monoester of estrogen, cis 13 docosenoic acid (Erucic acid), and the C-24 fatty acid monoester of estrogen, cis 15 tetracosenoic acid (Nervonic acid) are also effective and are included in this disclosure. In addition, synthesized combination molecules formed when a monounsaturated fatty acid of 20 carbon atoms or more is joined via an ester, ether, or amide bond to either a steroid or any molecule containing a perhydrocyclopentanophenanthrene nucleus or perhydrocyclopentanophenanthrene nucleus derivative are also included in this invention. The fatty-acid monoesters mimic the function of estrone monooleate, as a signal that informs the brain of the size of fat tissue mass. In preferred pharmaceutical and/or cosmetic compositions for intravenous injection the monoester is incorporated in a lipidic suspension, prepared from lipoproteins or from liposome components, such as soy oil and egg phospholipids. When administered to rats with a 15% of total adipose tissue, they produce weight reduction of about 10%, by a new and unexpected mechanism. They are useful for the treatment of obesity and/or overweight in mammals, with the advantages of high efficacy and low toxicity.

    摘要翻译： 用于治疗肥胖和/或超重的药物和/或化妆品组合物含有有效量的雌激素和脂肪酸的脂肪酸单酯，其中雌激素优选为雌酮，己烯雌酚，雌三醇，雌二醇或乙炔雌二醇，脂肪酸 酸是二十碳烯酸，特别是顺式11二十碳烯酸，尽管顺式5，顺式8和顺式13二十碳烯酸也是有效的。 雌激素的C-22脂肪酸单酯，顺式十二碳二烯酸（芥酸）和雌激素的C-24脂肪酸单酯，顺式十五碳二烯酸（Nervonic acid）也是有效的，并且包括在本公开中。 此外，本发明还包括通过酯，醚或酰胺键将20个或更多个碳原子的单不饱和脂肪酸形成的合成组合分子与类固醇或含有全氢环戊苯醌核的任何分子或全氢环戊烷菲核衍生物结合 。 脂肪酸单酯模仿雌酮单油酸酯的功能，作为通知大脑脂肪组织质量大小的信号。 在用于静脉内注射的优选药物和/或化妆品组合物中，将单酯掺入由脂蛋白或脂质体组分如大豆油和蛋磷脂制备的脂质悬浮液中。 当给予15％的总脂肪组织的大鼠时，它们通过新的和意想不到的机制产生约10％的体重减轻。 它们可用于治疗哺乳动物肥胖和/或超重，具有疗效高，毒性低的优点。

    Anti-viral compounds
    8.
    发明授权
    Anti-viral compounds 失效
    抗病毒化合物

    公开(公告)号：US6103923A

    公开(公告)日：2000-08-15

    申请号：US214535

    申请日：1999-01-06

    申请人： Scott C. Mauldin ,  John E. Munroe

    发明人： Scott C. Mauldin ,  John E. Munroe

    IPC分类号： C07C69/00 ,  C07C251/42 ,  C07C249/02 ,  C07C249/04

    CPC分类号： C07C69/00 ,  C07C251/42 ,  C07C2103/00 ,  C07C2103/26

    摘要： The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.

    摘要翻译： PCT No.PCT / US97 / 07527 Sec。 371日期1999年1月6日 102（e）1999年1月6日PCT PCT 1997年5月2日PCT公布。 公开号WO97 / 41861 日期1997年11月13日本发明通过抑制病毒与宿主细胞的融合来提供抑制包膜病毒的化合物。 感染的细胞，易感染的细胞或有需要的哺乳动物可能会抑制病毒。